
AngioDynamics (ANGO) Stock Forecast & Price Target
AngioDynamics (ANGO) Analyst Ratings
Bulls say
AngioDynamics Inc. is experiencing growth in its customer base, particularly in the OBL and hospital settings, which is positively impacting its average selling prices (ASP) and contributing to overall revenue enhancement. The company is demonstrating a significant improvement in gross margins, currently reported at 52.5%, driven by manufacturing initiatives and a favorable shift in revenue mix towards higher Med-Tech revenues. Management's confidence in continued growth is supported by the acquisition of new customers, increased utilization in existing accounts, and successful price increases across its product offerings.
Bears say
AngioDynamics Inc. faces potential financial pressures, as management anticipates $4 million to $6 million in tariff headwinds, which could negatively impact profitability. In addition, expectations for inventory costs in the second half of fiscal year 2026 are facing increased pressure from rising raw material prices. Although the sales of NanoKnife disposables exceeded projections, reliance on capital sales raises concerns about future demand sustainability in the disposable segment.
This aggregate rating is based on analysts' research of AngioDynamics and is not a guaranteed prediction by Public.com or investment advice.
AngioDynamics (ANGO) Analyst Forecast & Price Prediction
Start investing in AngioDynamics (ANGO)
Order type
Buy in
Order amount
Est. shares
0 shares